Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRGX

PRGX Global (PRGX) Stock Price, News & Analysis

PRGX Global logo

About PRGX Global Stock (NASDAQ:PRGX)

Advanced Chart

Key Stats

Today's Range
$7.69
$7.71
50-Day Range
$7.56
$7.71
52-Week Range
$1.77
$7.89
Volume
101,813 shs
Average Volume
290,461 shs
Market Capitalization
$181.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGX Global and its competitors with MarketBeat's FREE daily newsletter.

PRGX Stock News Headlines

When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.
See More Headlines

PRGX Stock Analysis - Frequently Asked Questions

PRGX Global, Inc. (NASDAQ:PRGX) released its quarterly earnings data on Tuesday, October, 27th. The business services provider reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.06. The business services provider earned $41.53 million during the quarter, compared to analysts' expectations of $39.59 million. PRGX Global had a negative net margin of 2.95% and a positive trailing twelve-month return on equity of 10.13%.

Based on aggregate information from My MarketBeat watchlists, some other companies that PRGX Global investors own include Energy Transfer (ET), CymaBay Therapeutics (CBAY), Ford Motor (F), Advanced Micro Devices (AMD), Actinium Pharmaceuticals (ATNM), Dynavax Technologies (DVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
10/27/2020
Today
8/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Engineering, Accounting, Research, Management & Related Services
Sub-Industry
Data Processing & Outsourced Services
Current Symbol
NASDAQ:PRGX
CIK
1007330
Fax
N/A
Employees
1,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
35.05
P/E Growth
1.32
Net Income
-$13.72 million
Net Margins
-2.95%
Pretax Margin
N/A
Return on Equity
10.13%
Return on Assets
4.25%

Debt

Debt-to-Equity Ratio
0.54
Current Ratio
2.07
Quick Ratio
2.07

Sales & Book Value

Annual Sales
$169.76 million
Price / Sales
1.07
Cash Flow
$0.41 per share
Price / Cash Flow
18.88
Book Value
$2.30 per share
Price / Book
3.35

Miscellaneous

Outstanding Shares
23,561,000
Free Float
N/A
Market Cap
$181.66 million
Optionable
Optionable
Beta
1.36
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PRGX) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners